Q
QuantAbundanceAbundance, Quantified.

News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

30,447 signal articles · 141 in last 24h · 154,069 total before filter · latest 55m ago
141last 24h
873last 7d
146● bullish (7d)
98● bearish (7d)
214publishers
AllMacro206Earnings108M&A125Regulatory22Product21Analyst17
✕ clear all filterssentiment: bearishSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
Amazon Faces Another Worker Lawsuit. Is Employment Scrutiny Becoming an Investor Risk? (Ready for Vardah)
Insider Monkey3h agobearish
Amazon Faces Another Worker Lawsuit. Is Employment Scrutiny Becoming an Investor Risk? (Ready for Vardah)

Amazon.com, Inc. (NASDAQ:AMZN) is no stranger to disputes over its massive workforce. A lawsuit filed earlier this month has put that part of the business back under scrutiny, with four former warehouse employees seeking to represent thousands of workers in a proposed nationwide class action alleging systematic discrimination against pregnant employees. READ ALSO: Walmart Settles […]

Adobe Stock Slides 18%: Value Play or Falling Knife?
Trefis4h agobearish
Adobe Stock Slides 18%: Value Play or Falling Knife?

Adobe (ADBE) stock has fallen about 18% from its August 31 high, and the question is whether to buy. Its own trading history warrants caution: after past sharp drops, the stock was higher a year later only half the time. And Adobe is trading some near-term recurring-revenue growth for free users, a bet management says will play out over 2027.

A Guide to Owning Bonds When They Are Selling Off
The Wall Street Journal5h agobearish
A Guide to Owning Bonds When They Are Selling Off

A bond-market rout pushed the 10-year Treasury yield to the highest since 2007, but it doesn’t erase the value of fixed income in a diversified portfolio. Over 80% of the global bond market now yields above 4%, according to BlackRock. The asset manager says the average yield in a bond portfolio it tracks has more than doubled from five years earlier.

Kinross Gold shares tumble on weaker La Coipa, Round Mountain outlook
Proactive5h agobearish
Kinross Gold shares tumble on weaker La Coipa, Round Mountain outlook

Kinross Gold Corporation (TSX:K) shares fell nearly 13% Thursday after the miner cut its 2026 and 2027 production guidance, citing weather and recovery issues at La Coipa and lower mining rates, grades and recoveries at Round Mountain. Although Jefferies has maintained its Buy rating on the...

Palantir Technologies (PLTR) Ties Aviation AI Push To Fresh Short Seller Pressure
Simply Wall St.5h agobearish
Palantir Technologies (PLTR) Ties Aviation AI Push To Fresh Short Seller Pressure

Palantir Technologies (NasdaqGS:PLTR) is back in focus as Surf Air Mobility appoints former Palantir executive Barrett Brown as President of SurfOS, a Palantir-powered platform for commercial aviation software. SurfOS is positioned as Surf Air Mobility's operating system for airline and aircraft partners, with Palantir's software underpinning its data and AI capabilities. Investor Michael Burry has expanded short positions that include exposure to Palantir, which signals prominent skepticism...

Carnival hit by rising oil costs as BofA cuts price target
Proactive6h agobearish
Carnival hit by rising oil costs as BofA cuts price target

Carnival Corp (NYSE:CCL) shares have fallen 27% since August as surging oil prices raise concerns about fuel costs, prompting Bank of America to cut its price target on the cruise operator to $38 from $42 while maintaining a ‘buy’ rating. The broker said Carnival, as the only unhedged major...

Merck Says Investigational Diabetes-Related Blindness Drug at Par With Roche’s Medicine
Benzinga6h agobearish
Merck Says Investigational Diabetes-Related Blindness Drug at Par With Roche’s Medicine

Merck & Co. Inc. (NYSE:MRK) on Thursday announced topline results from the pivotal Phase 2b/3 BRUNELLO trial in adults with diabetic macular edema (DME). DME is a serious eye complication of diabetes where high blood sugar damages tiny retinal blood vessels, causing them to leak fluid into the macula (the central part of the retina responsible for sharp vision) and making it swell. BRUNELLO is the first of two Phase 2b/3 trials evaluating remigromig (MK-3000, formerly EYE103), an investigational